Shima Shima H H Tsurita Tsurita G G Wada Wada S S Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma Cancer Sci Cancer Sci 2019 2019 110 110 8 8 2378 2378 2385 2385 supplied-pmid 31218770? This evidence concerns the gene BIRC5 and pancreatic adenocarcinoma.